Post-marketing safety surveillance of Haemophilus influenzae Type b conjugate vaccine in children aged 3 months to 5 years in Jiangsu, China
Yuxuan Zhou, Rong Tang, Mingwei Wei, Xinglu Peng, Ruifan Shen, Jingxin Li · 2026
Read Post-marketing safety surveillance of Haemophilus influenzae Type b conjugate vaccine in children aged 3 months to 5 years in Jiangsu, China by Yuxuan Zhou, Rong Tang, Mingwei Wei, Xinglu Peng, Ruifan Shen, Jingxin Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13224760.txt.
Description
Yuxuan Zhou and colleagues run a 2026 safety surveillance study of a Hib conjugate vaccine given to young children in Jiangsu Province, China. The vaccine protects against Haemophilus influenzae type b, a cause of meningitis and pneumonia in early childhood. More than nine thousand children between three months and five years were followed through two parallel systems.
In active surveillance, where guardians logged every event for thirty days, about seven percent of children had some adverse event, almost all mild or moderate. The passive reporting system captured a far lower rate, with fever the commonest complaint. No vaccine-related serious reactions appeared in either system, and the gap between systems shows how reporting method shapes apparent rates.
Catalog record
| CREATOR | Yuxuan Zhou, Rong Tang, Mingwei Wei, Xinglu Peng, Ruifan Shen, Jingxin Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |